Skip to main content
Loading ResearchHub…
Cited by — Exploring patient and clinician perspectives for homologous recombination deficient (HRD) biomarker testing to guide precision medicine for advanced ovarian cancer treatment: A qualitative study | ResearchHub - ResearchHub